Other
Journal
Breaking News
- Study: 3D Mammography Reduces Recall Rates
Cancer detection also increased (May 23) - FDA Advisors Back New Sleep Drug, Suvorexant
Daytime somnolence is a concern (May 22) - New Approach for Influenza Vaccination Shows Promise in Early Testing
NIH scientists advance development of universal flu vaccine (May 22) - AHA Statement: Costs to Treat Stroke in U.S. May Double by 2030
Highest stroke incidence expected in people aged 45 to 64 years (May 22) - Positive Phase III Results for Extended-Release Topiramate in Epilepsy Patients
FDA review expected in December (May 22)
Free App
Managed Care, and P&T are available for free on multiple mobile platforms and devices. For Apple and iOS devices, visit the Apple Store and download the free digital application for Managed Care and P&T. Search for "Managed Care," "Pharmacy and Therapeutics," or "MediMedia."
Users of Android, Blackberry, Nook, and Kindle can view the mobile version on their respective devices by visiting these Web sites: Managed Care and P&T.
Resources
Pharmacy Policies/Procedures: Forms and guidelines
Cost Calculators: Exclusive online tools to evaluate your pharmacy costs
Links: A comprehensive map of web links to the world of managed care pharmacy
P&T Community
Update Your Registration Profile
Haven't received your weekly newsletters about the new features on PTcommunity.com? Check your newsletter status by clicking here. Scroll down to the question, 'Check here if you would like to receive our e-newsletter?' and choose 'Yes' or 'No.'
Having trouble with the site? Send an email.
P&T Journal
for May 2013
Features
FDA Strategies to Prevent and Respond to Drug Shortages
Meeting Highlights
Departments
Prescription: Washington
FDA Pushes Plans for Drug Compounding
Medication Errors
Improved Safety Needed in Handling Elastomeric Reservoir Balls Used for Pain Relief
About P&T
Editor-in-Chief
David Nash, M.D, M.B.A., Editor in Chief
View the rest of the Editorial Board here.
Contacts:
Editor: ssherritze@medimedia.comAdvertising: mliberti@medimedia.com
Circulation: lgardineer@medimedia.com
Production: wpeart@medimedia.com
Rate Card & Production Specifications
BPA Statement
Call For Papers
P&T Journal is now accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please see our author guidelines below or contact the editor, Sonja Sherritze, via phone 267-685-2779 or email: ssherritze@medimedia.com.Subscribe to P&T
Print Edition
P&T TV
Who Will Pay for High-Cost Biologics?
Insurance coverage was never meant to handle new pharmaceutical breakthroughs on the radar — breakthroughs that can cost anywhere from $90,000 to $300,000 a year per patient, says F. Randy Vogenberg, RPh, PhD, principal of the Institute for Integrated Healthcare and a member of P&T’s Editorial Board. There will be pressure on everybody to find a way to somehow control these costs.Recent Headlines
- Doctors and Hospitals’ Use of Health IT Has Doubled Since 2012
HHS says more than half of U.S. docs adopt electronic health records (May 22) - NIH Funds Studies to Improve Prediabetes and Type 2 Diabetes Treatment
Trials for adults and youth compare treatments in newly diagnosed subjects (May 22) - Positive Phase III Results With Simeprevir in Hepatitis Patients
NDA submitted for treatment of genotype 1 hepatitis C (May 21) - Survey: Emerging Agents Offer Advantages Over Current Breast Cancer Therapies
Improvements in efficacy endpoints are key drivers of prescribing (May 21) - Vitamin C Kills Drug-Resistant TB
Researchers find new way to attack infection (May 21) - Multiple Sclerosis Drug Plegridy (Peginterferon) Submitted for FDA Review
Treatment significantly reduces disease activity in phase III trial (May 21) - Positive Phase III Results With Sublingual Sufentanil in Management of Postoperative Pain
Sublingual NanoTabs reduce pain intensity in third pivotal study (May 21) - Another Kink in Health Care Law: How Will the ‘Unbanked’ Buy Insurance?
About 51 million U.S. adults don’t have traditional bank accounts (May 20) - Improved Quality of Life Is Major Unmet Need in COPD Treatment, Survey Finds
Indacaterol/glycopyrronium has advantages over current therapies (May 20) - Study of Lymphoma Drug Halted
Inotuzumab ozogamicin unlikely to help survival (May 20)
